Why the study?
Pre-capillary pulmonary hypertension carries high morbidity and frequent emergency department visits, and web-based symptom monitoring programs may support self-management and early decompensation detection.
Does a web-based symptom monitoring program reduce symptom interference, improve physical activity, and decrease emergency department readmissions in patients with pre-capillary pulmonary hypertension?
Does a web-based symptom monitoring program reduce symptom interference, improve physical activity, and decrease emergency department readmissions in patients with pre-capillary pulmonary hypertension?
A web-based symptom monitoring program significantly improves physical activity and reduces emergency department readmissions in patients with pre-capillary pulmonary hypertension.
May support web-based monitoring to ease symptoms and cut ED visits in pre-capillary PH; leaves open need for larger confirmatory trials.
Background: Pre-capillary pulmonary hypertension (PH) is a progressive and incurable disease characterized by high morbidity, frequent emergency department (ED) visits, and persistently poor survival despite targeted therapies. Web-based symptom monitoring programs offer a promising, non-invasive approach to support self-management and enable the early detection of decompensation. Objective: This study aimed to evaluate the effects of a web-based symptom-monitoring program on symptom interference, physical activity, and ED readmission in patients with pre-capillary PH. Methods: This parallel-group, single-blind, randomized controlled trial recruited patients with precapillary PH from a cardiology outpatient department in northern Taiwan. Patients were included if they had been diagnosed with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and had a mean pulmonary arterial pressure of >20 mmHg confirmed via right heart catheterization. Participants were randomized into 2 groups: an intervention group (n=26), which received a 6-month symptom monitoring program delivered via a web-based application, or a control group (n=25), which received standard care. Outcomes were assessed by comparing measures at baseline (enrollment) with measures at 3, 6, and 9 months postintervention. The primary outcome was symptom interference, and the secondary outcomes included physical activity based on the 6-minute walk test, hemodynamic data, and readmissions to the ED. Changes in baseline measurements were analyzed using generalized estimating equations. Results: The mean age of the 51 participants was 59.6 (SD 13.6) years. Most patients were diagnosed with connective tissue disease-associated pulmonary arterial hypertension (39.2%), with a mean duration of PH since diagnosis of 3.38 (SD 2.55) years. The patient characteristics did not differ significantly between the groups. Compared with the control group, the intervention group experienced greater reduction in symptom interference, and over the 9-month intervention period, the intervention group showed a significantly greater improvement in the 6-minute walk test, with the distance increasing by an average of 9.8 meters every 3 months (β=9.81; 95% CI 0.93 to 18.70; P=.03). Additionally, generalized estimating equations analysis demonstrated that, compared to the control group, the intervention group had a 65% decrease (β=-1.03; OR=0.35; P=.04) in the likelihood of ED readmissions for every 3-month interval during the 9-month study period. Conclusions: A web-based symptom monitoring program effectively reduced symptom interference, improved physical activity, and decreased ED visits in patients with pre-capillary PH.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: